Genotoxic Drugs Induce Interaction of the c-Abl Tyrosine Kinase and the Tumor Suppressor Protein p53

This publication has 23 references indexed in Scilit:

• The stress response to ionizing radiation involoves c-Abl-dependent phosphorylation of SHPTP1.
  Proceedings of the National Academy of Sciences, 1996
• Abl-interactor-1, a novel SH3 protein binding to the carboxy-terminal portion of the Abl protein, suppresses v-abl transforming activity.
  Genes & Development, 1995
• Abi-2, a novel SH3-containing protein interacts with the c-Abl tyrosine kinase and modulates c-Abl transforming activity.
  Genes & Development, 1995
• Src homology 2 domain as a specificity determinant in the c-Abl-mediated tyrosine phosphorylation of the RNA polymerase II carboxyl-terminal repeated domain.
  Proceedings of the National Academy of Sciences, 1995
• The nuclear tyrosine kinase c-abl negatively regulates cell growth
  Cell, 1994
• Abl protein-tyrosine kinase selects the Crk adapter as a substrate using SH3-binding sites.
  Genes & Development, 1994
• The COOH terminus of the c-Abl tyrosine kinase contains distinct F- and G-actin binding domains with bundling activity [published erratum appears in J Cell Biol 1994 Mar;124(5):865]
  The Journal of cell biology, 1994
• Tyrosine phosphorylation of mammalian RNA polymerase II carboxyl-terminal domain.
  Proceedings of the National Academy of Sciences, 1993
• Cell Cycle—Regulated Binding of c-Abl Tyrosine Kinase to DNA
  Science, 1992
• The mouse type IV c-abl gene product is a nuclear protein, and activation of transforming ability is associated with cytoplasmic localization
  Cell, 1989